跳至主要内容
临床试验/NCT02997683
NCT02997683Unknown不适用

Influence of Training With Whole Body Vibration Device on Quality of Life (QoL), Exercise Capacity, as Well as on the Effects of Muscle Power and Muscle Function in Patients With Pulmonal Arterial Hypertension (PAH) in an Extended 3-month Home Based Training. Background and Rationale for the Proposal: Capacity and the Ability to Exercise, in Patients With PAH is Limited. Primary Scientific Question Addressed:Changes in Muscle Power, Changes in 6-Minute Walk Distance (6MWD) and Changes in QoL Are to be Evaluated.

Klinikum der Universität Köln2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2018年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
80
试验地点
2
主要终点
Changes in 6 Minute Walking distance

研究概览

简要总结

In order to evaluate Long term effects of whole Body Vibration (wbv) in patients with PAH and CTEPH patients will get a training device to use at home for 3 months. Patients in the Intervention group will be introduced in the training program on the wbv-device in the study center 3-4 times and baseline Parameters will be collected before start of the home based training. Patients randomized into the placebo arm be introduced into the training program according to the interventional arm but not perfoming the exercises on the wbv-device but on the floor.

详细描述

Screening (day -21 until day -7): Subjects will be evaluated according to In- and Exclusion critera

Randomization (day -7): Subjects will be randomized to either Intervention Group (training on wbv platform) or non-Intervention Group (training without wbv).

Introduction Week -1(-7d-d1): All subjects will receive introduction in their training

Month 1:

Day 1: From this day subjects are supposed to start their training accoridng to protocol

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women age 18-90 years
  • Signed informed consent
  • Symptomatic PAH (idiopathic, hereditary or associated with systemic scleroderma)
  • Persistend or inoperable CTEPH
  • Invasively confirmed PAH
  • 6MWT ≥ 50 - 450 m
  • Stable specific therapy for at least 6 weeks
  • Ability to perform bike test
  • Ability to perform wbv training
  • NYHA/WHO-FC II-III

排除标准

  • any other PAH/PH than idiopathic, hereditary, associated with systemic scleroderma or CTEPH
  • Rehabilitation or other training concept performed within 6 weeks before inclusion
  • pregnancy
  • acute thrombosis
  • newly implanted Hip or Knee
  • recent bone fracture
  • Disability to confirm consent
  • NYHA/WHO-FC IV
  • 6MWD below 50 or above 450 m

研究组 & 干预措施

3-month home based training on whole body vibration platform

Experimental

This Group will receive a training device to perform their given exercises on

干预措施: Body Vibration platform GALILEO (Device)

3-month home based training on floor

Placebo Comparator

This Group will perform their given exercises at home on the floor

干预措施: exercises at home on the floor (Other)

结局指标

主要结局

Changes in 6 Minute Walking distance

时间窗: 4 weeks interm analysis

次要结局

  • Changes in Quality of Life(4 weeks)
  • Changes in Peak Oxygen uptake in cardiopulmonary exercise testing (CPET)(4 weeks)

研究者

发起方
Klinikum der Universität Köln
申办方类型
Other
责任方
Principal Investigator
主要研究者

Felix Gerhardt

Dr. med.

Klinikum der Universität Köln

研究点 (2)

Loading locations...

相似试验